Ghana's oil production falls for fifth consecutive year, according to PIAC report
Ghana narrowly missed matching its 2023 crude oil production levels, recording a marginal shortfall of just 0.01%, equivalent to 7,000 barrels. By the end of 2024, total crude oil output stood at 48,240,010 barrels, slightly below the 48,247,037 barrels produced in 2023.
Ghana nearly matched its 2023 crude oil production, with a marginal shortfall of just 0.01%
Total crude oil output by the end of 2024 was 48,240,010 barrels, slightly below the 2023 production of 48,247,037 barrels
PIAC's 2024 Annual Report highlighted concerns about the declining production from the TEN Field
The 2024 figure marks the closest Ghana has come to reversing the downward trend in annual oil production since 2019.
PIAC releases 14th Annual Report on Petroleum revenue use
This information was revealed in the 2024 Annual Report on the Use and Management of Petroleum Revenue, published by the Public Interest and Accountability Committee (PIAC). The report—PIAC's 14th annual and 27th statutory submission—was officially launched on Tuesday, 29 April 2025.
Presenting highlights of the report, PIAC Chairman Mr Constantine Kudzedzi disclosed that the Jubilee Field contributed the largest share of production, accounting for 66% of Ghana's total output. The Sankofa Gye-Nyame (SGN) and Tweneboa-Enyenra-Ntomme (TEN) fields accounted for 20% and 14% respectively.
PIAC expressed concerns about the continued decline in production from the TEN Field, describing the field's output as the lowest among the three producing sites. The committee urged the government to undertake both technical and cost audits to determine the root causes of the declining performance.
'The TEN Field turned out the lowest production among the three producing fields, with substantially high production and development cost trends raising concerns about the viability of the field,' the report noted.
Ghana Group contributes $89.44 Million in oil lifting
The report further indicated that the Ghana Group contributed approximately $89.44 million in petroleum revenue through a total lifting of $73.91 million in 2024. This performance reflects ongoing challenges in optimising returns from Ghana's petroleum sector amid rising operational costs.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29-05-2025
- Yahoo
ROYAL CANADIAN MINT REPORTS PROFITS AND PERFORMANCE FOR Q1 2025
OTTAWA, ON, May 29, 2025 /CNW/ - The Royal Canadian Mint (the "Mint") is announcing its financial results for the first quarter of 2025. These results provide insights into the Mint's activities, the impacts of economic uncertainties and trade barriers on its businesses and its expectations for the next 12 months. "Throughout the first quarter, the Royal Canadian Mint navigated the uncertainties of a challenging and unpredictable global market," said Marie Lemay, President and CEO of the Royal Canadian Mint. "Our talented people invested a lot of time and energy over the last several months to evaluate the impact of U.S. tariffs and respond to the market volatility in a way that positions the Mint to withstand these headwinds over the long-term by adjusting our priorities and capitalizing on opportunities." To read the Mint's First Quarter Report for 2025, please visit The Mint's 2024 Annual Report, including its audited financial statements as at and for the year ended December 31, 2024, was submitted to the Minister of Finance on March 27, 2025, in accordance with the Financial Administration Act Section 50(1). As of the date of this earnings release, the Mint's 2024 Annual Report has not been tabled in Parliament and will not be available for public release until the tabling occurs. About the Royal Canadian MintThe Royal Canadian Mint is the Crown corporation responsible for the minting and distribution of Canada's circulation coins. The Mint is one of the largest and most versatile mints in the world, producing award-winning collector coins, market-leading bullion products, as well as Canada's prestigious military and civilian honours. As an established London and COMEX Good Delivery refiner, the Mint also offers a full spectrum of best-in-class gold and silver refining services. As an organization that strives to take better care of the environment, to cultivate safe and inclusive workplaces and to make a positive impact on the communities where it operates, the Mint integrates environmental, social and governance practices in every aspect of its operations. For more information on the Mint, its products and services, visit Follow the Mint on LinkedIn, Facebook and Instagram. SOURCE Royal Canadian Mint (RCM) View original content: Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Business Wire
28-05-2025
- Business Wire
Marti Technologies, Inc. Files Annual Report on Form 20-F for Fiscal Year 2024
ISTANBUL, Türkiye--(BUSINESS WIRE)--Marti Technologies, Inc. ('Marti' or the 'Company') (NYSE American: MRT), Türkiye's leading mobility super app, announced that it has filed its annual report on Form 20-F, including its financial results, for the fiscal year ended December 31, 2024 (the '2024 Annual Report') with the U.S. Securities and Exchange Commission. The 2024 Annual Report can be accessed under the 'Financial Info' section of the Company's investor relations website at In addition, Marti shareholders may receive, free of charge, a hard copy of the Company's complete financial statements by requesting a copy from the contact below. About Marti: Founded in 2018, Marti is Türkiye's leading mobility app, offering multiple transportation services to its riders. Marti operates a ride-hailing service that matches riders with car, motorcycle, and taxi drivers, and operates a large fleet of rental e-mopeds, e-bikes, and e-scooters. All of Marti's offerings are serviced by proprietary software systems and IoT infrastructure. For more information, visit
Business Wire
23-05-2025
- Business Wire
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2024 Annual Report
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (' SINOVAC ' or the ' Company '), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 16, 2025 (the ' Notification Letter ') from Nasdaq Listing Qualifications (' Nasdaq '), stating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) since the Company did not timely file its annual report on Form 20-F for the year ended December 31, 2024 (the ' 2024 Annual Report '). Pursuant to the Nasdaq Listing Rules, the Company has 60 calendar days from the date of the Notification Letter, or until July 15, 2025, to submit a plan to regain compliance (the ' Compliance Plan '). If Nasdaq accepts the Compliance Plan, it may grant the Company an exception until November 11, 2025, to regain compliance. If Nasdaq does not accept the Compliance Plan, the Company will have the opportunity to appeal that decision to a hearing panel under Nasdaq Listing Rule 5815(a). As previously disclosed, on April 15, 2025, Grant Thornton Zhitong Certified Public Accountants LLP (' Grant Thornton ') notified the Company that it had resigned as the Company's independent registered public accounting firm. The Company's audit committee has commenced and is diligently conducting a process to evaluate and select a new independent registered public accounting firm so that the 2024 Annual Report can be filed as soon as practicable. The Company intends to submit the Compliance Plan within the prescribed 60-day period ending July 15, 2025. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected hand-foot-mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc. The COVID-19 vaccine, CoronaVac ®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive ®, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive ®, is an innovative vaccine under 'Category 1 Preventative Biological Products' and commercialized in China in 2016. In 2022, SINOVAC's Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO. SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1 ®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu ®, to the Chinese government stockpiling program. SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations. For more information, please visit the Company's website at Safe Harbor Statement This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as 'may,' 'will,' 'expect,' 'anticipate,' 'aim,' 'estimate,' 'intend,' 'plan,' 'believe,' 'potential,' 'continue,' 'is/are likely to' or other similar expressions, including the Company's statements related to the Compliance Plan, and timing and actions taken to regain compliance with Nasdaq listing rules. Such statements are based upon the Company's current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, including without limitation risks, uncertainties and factors related to the timing of engaging independent auditors and completion of the audits of required fiscal periods, completion and filing of the 2024 Annual Report, the Compliance Plan, and actions taken to regain compliance with the Nasdaq listing rules, all of which are difficult to predict and many of which are beyond the Company's control, which may cause the Company's actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
